Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1567-2026
  • E-ISSN: 1875-5739

Abstract

Background

Silent Brain Infarction (SBI) has been found to be linked to an increased risk of cognitive impairment and future symptomatic stroke. Atrial fibrillation is a significant risk factor for SBI. Even in low-risk atrial fibrillation patients, the incidence of SBI remains high. This study aims to investigate the risk factors for SBI in Nonvalvular Atrial Fibrillation (NVAF) patients with a CHADS-VASc score of 0 to 1.

Methods

A total of 301 consecutive low-risk NVAF patients (male: CHADS-VASc=0, female: CHADS-VASc=1) were enrolled. According to brain Magnetic Resonance Imaging (MRI), patients were divided into SBI (n=90) and non-SBI (n=211) groups. Baseline characteristics, blood parameters, and echocardiography results were analyzed. Multivariate logistic regression was performed to identify independent predictors. Receiver Operating Characteristic (ROC) curve analysis was used to evaluate the diagnostic power of the relevant risk factors.

Results

The study revealed that neutrophil count, monocyte count, Platelet-To-Lymphocyte Ratio (PLR), neutrophil-to-high density lipoprotein cholesterol ratio (NHR), and left atrial diameter (LAD) were significantly higher in the SBI group than non-SBI group ( <0.05). Multivariate logistic regression analysis identified PLR (OR, 1.004; 95%CI 1.001-1.007; =0.026) and LAD (OR 1.092; 95%CI 1.054-1.130; <0.001) as the independent risk factors associated with SBI. The ROC showed that the Area Under the Curve (AUC) of PLR is 0.589 (95%CI 0.515-0.662; =0.015) with an optimal cut-off point of 151 (sensitivity 43.3%, specificity 74.6%). The AUC of LAD is 0.676 (95%CI 0.606-0.746; <0.001) with an optimal cut-off point of 39 mm (sensitivity 61.1%, specificity 72.0%). The AUC of PLR combined with LAD is 0.711 (95%CI 0.646-0.777; <0.001) with a sensitivity of 63.3% and specificity of 73.5% for SBI.

Conclusion

PLR and LAD can be independent risk factors for SBI in NVAF patients with low CHADS-VASc scores. The combination of the two factors can enhance the predictive ability of SBI in these patients.

Loading

Article metrics loading...

/content/journals/cnr/10.2174/0115672026354260241218115435
2024-12-26
2025-04-07
Loading full text...

Full text loading...

References

  1. KühneM. KrisaiP. CoslovskyM. RodondiN. MüllerA. BeerJ.H. AmmannP. AuricchioA. MoschovitisG. HayozD. KobzaR. ShahD. StephanF.P. SchläpferJ. Di ValentinoM. AeschbacherS. EhretG. EkenC. MonschA. RotenL. SchwenkglenksM. SpringerA. SticherlingC. ReichlinT. ZuernC.S. MeyreP.B. BlumS. SinneckerT. WürfelJ. BonatiL.H. ConenD. OsswaldS. Silent brain infarcts impact on cognitive function in atrial fibrillation.Eur. Heart J.202243222127213510.1093/eurheartj/ehac02035171989
    [Google Scholar]
  2. GuptaA. GiambroneA.E. GialdiniG. FinnC. DelgadoD. GutierrezJ. WrightC. BeiserA.S. SeshadriS. PandyaA. KamelH. Silent brain infarction and risk of future stroke.Stroke201647371972510.1161/STROKEAHA.115.01188926888534
    [Google Scholar]
  3. De MarchisG.M. KrisaiP. WerlenL. SinneckerT. AeschbacherS. DittrichT.D. PolymerisA.A. CoslovskyM. BlumM.R. RodondiN. ReichlinT. MoschovitisG. WuerfelJ. LyrerP.A. FischerU. ConenD. KastnerP. ZieglerA. OsswaldS. KühneM. BonatiL.H. Biomarker, imaging, and clinical factors associated with overt and covert stroke in patients with atrial fibrillation.Stroke202354102542255110.1161/STROKEAHA.123.04330237548011
    [Google Scholar]
  4. FanningJ.P. WongA.A. FraserJ.F. The epidemiology of silent brain infarction: A systematic review of population-based cohorts.BMC Med.201412111910.1186/s12916‑014‑0119‑025012298
    [Google Scholar]
  5. ZhouZ. YouS. SakamotoY. XuY. DingS. XuW. LiW. YuJ. WangY. HarrisK. DelcourtC. ReevesM.J. LindleyR.I. ParsonsM.W. WoodwardM. AndersonC. DuX. PuJ. WardlawJ.M. CarcelC. Covert cerebrovascular changes in people with heart disease.Neurology20241028e20920410.1212/WNL.000000000020920438531010
    [Google Scholar]
  6. ChenJ. ZhouM. WangH. ZhengZ. RongW. HeB. ZhaoL. Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc score.J. Thromb. Thrombolysis202253252353110.1007/s11239‑021‑02554‑934476733
    [Google Scholar]
  7. DoluA.K. AkçayF.A. AtalayM. KaracaM. Systemic immune-inflammation index as a predictor of left atrial thrombosis in nonvalvular atrial fibrillation.J. Tehran Univ. Heart Cent.2023182879310.18502/jthc.v18i2.1331737637278
    [Google Scholar]
  8. YanY.K. HuangH. LiD.P. AiZ.Y. LiX. SunZ. Prognostic value of the platelet-to-lymphocyte ratio for outcomes of stroke: A systematic review and meta-analysis.Eur. Rev. Med. Pharmacol. Sci.202125216529653810.26355/eurrev_202111_2709534787855
    [Google Scholar]
  9. TokunagaK. KogaM. YoshimuraS. OkadaY. YamagamiH. TodoK. ItabashiR. KimuraK. SatoS. TerasakiT. InoueM. ShiokawaY. TakagiM. KamiyamaK. TanakaK. TakizawaS. ShiozawaM. OkudaS. KamedaT. NagakaneY. HasegawaY. ShibuyaS. ItoY. MatsuokaH. TakamatsuK. NishiyamaK. KarioK. YagitaY. MizoguchiT. FujitaK. AndoD. KumamotoM. MiwaK. ArihiroS. ToyodaK. Left atrial size and ischemic events after ischemic stroke or transient ischemic attack in patients with nonvalvular atrial fibrillation.Cerebrovasc. Dis.202049661962410.1159/00051139333176314
    [Google Scholar]
  10. SmithE.E. SaposnikG. BiesselsG.J. DoubalF.N. FornageM. GorelickP.B. GreenbergS.M. HigashidaR.T. KasnerS.E. SeshadriS. Prevention of stroke in patients with silent cerebrovascular disease: A scientific statement for healthcare professionals from the american heart association/american stroke association.Stroke2017482e44e7110.1161/STR.000000000000011627980126
    [Google Scholar]
  11. ChenL.Y. LopezF.L. GottesmanR.F. HuxleyR.R. AgarwalS.K. LoehrL. MosleyT. AlonsoA. Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study.Stroke20144592568257410.1161/STROKEAHA.114.00524325052319
    [Google Scholar]
  12. ChaM. ParkH.E. LeeM. ChoY. ChoiE. OhS. Prevalence of and risk factors for silent ischemic stroke in patients with atrial fibrillation as determined by brain magnetic resonance imaging.Am. J. Cardiol.2014113465566110.1016/j.amjcard.2013.11.01124360776
    [Google Scholar]
  13. VermeerS.E. LongstrethW.T.Jr KoudstaalP.J. Silent brain infarcts: a systematic review.Lancet Neurol.20076761161910.1016/S1474‑4422(07)70170‑917582361
    [Google Scholar]
  14. HermJ. SchurigJ. MartinekM.R. HöltgenR. SchirdewanA. KirchhofP. WieczorekM. PürerfellnerH. HeuschmannP.U. FiebachJ.B. HaeuslerK.G. MRI-detected brain lesions in AF patients without further stroke risk factors undergoing ablation - A retrospective analysis of prospective studies.BMC Cardiovasc. Disord.20191915810.1186/s12872‑019‑1035‑130871479
    [Google Scholar]
  15. MikiK. NakanoM. AizawaK. HasebeY. KimuraY. MorosawaS. AkashiT. MorishitaY. MiyataS. FukudaK. ShimokawaH. Risk factors and localization of silent cerebral infarction in patients with atrial fibrillation.Heart Rhythm20191691305131310.1016/j.hrthm.2019.03.01330898584
    [Google Scholar]
  16. Escudero-MartínezI. OceteR.F. ManchaF. VegaÁ. PiñeroP. López-RuedaA. FajardoE. AlgabaP. Fernández-EngoJ.R. Martín-SánchezE.M. Galvao-CarmonaA. Zapata-ArriazaE. LebratoL. Pardo-GalianaB. CabezasJ.A. AyusoM.I. GonzálezA. MonicheF. MontanerJ. Prevalence and risk factors of silent brain infarcts in patients with AF detected by 3T-MRI.J. Neurol.202026792675268210.1007/s00415‑020‑09887‑032410017
    [Google Scholar]
  17. BergD.D. RuffC.T. MorrowD.A. Biomarkers for risk assessment in atrial fibrillation.Clin. Chem.2021671879510.1093/clinchem/hvaa29833313695
    [Google Scholar]
  18. GalenkoO. JacobsV. BunchT.J. Biomarkers in the risk assessment for stroke and dementia in atrial fibrillation.Curr. Opin. Cardiol.20203511710.1097/HCO.000000000000068831574002
    [Google Scholar]
  19. GasparyanA.Y. AyvazyanL. MukanovaU. YessirkepovM. KitasG.D. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases.Ann. Lab. Med.201939434535710.3343/alm.2019.39.4.34530809980
    [Google Scholar]
  20. ChenC. GuL. ChenL. HuW. FengX. QiuF. FanZ. ChenQ. QiuJ. ShaoB. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential predictors of prognosis in acute ischemic stroke.Front. Neurol.20211152562110.3389/fneur.2020.52562133569032
    [Google Scholar]
  21. BakogiannisC. SachseM. StamatelopoulosK. StellosK. Platelet-derived chemokines in inflammation and atherosclerosis.Cytokine201912215415710.1016/j.cyto.2017.09.01329198385
    [Google Scholar]
  22. KojokK. El-KadiryA.E.H. MerhiY. Role of NF-κB in platelet function.Int. J. Mol. Sci.20192017418510.3390/ijms2017418531461836
    [Google Scholar]
  23. ZahorecR. Neutrophil-to-lymphocyte ratio, past, present and future perspectives.Bratisl. Med. J.2021122747448810.4149/BLL_2021_07834161115
    [Google Scholar]
  24. LiQ. NieJ. CaoM. LuoC. SunC. Association between inflammation markers and all-cause mortality in critical ill patients with atrial fibrillation: Analysis of the Multi-Parameter Intelligent Monitoring in Intensive Care (MIMIC-IV) database.Int. J. Cardiol. Heart Vasc.20245110137210.1016/j.ijcha.2024.10137238435383
    [Google Scholar]
  25. AltintasO. TasalA. NiftaliyevE. KucukdagliO.T. AsilT. Association of platelet-to-lymphocyte ratio with silent brain infarcts in patients with paroxysmal atrial fibrillation.Neurol. Res.201638975375810.1080/01616412.2016.121035727456433
    [Google Scholar]
  26. SuwaY. MiyasakaY. TaniguchiN. HaradaS. NakaiE. ShiojimaI. Atrial fibrillation and stroke: importance of left atrium as assessed by echocardiography.J. Echocardiogr.2022202697610.1007/s12574‑021‑00561‑635066798
    [Google Scholar]
  27. ZhouM. ChenJ. WangH. XiS. GanT. ZhaoL. Independent risk factors of atrial thrombosis in patients with nonvalvular atrial fibrillation and low CHA2DS2-VASc scores.Nan Fang Yi Ke Da Xue Xue Bao20214181243124910.12122/j.issn.1673‑4254.2021.08.1734549717
    [Google Scholar]
  28. OgataT. MatsuoR. KiyunaF. HataJ. AgoT. TsuboiY. KitazonoT. KamouchiM. IbayashiS. KusudaK. FujiiK. NagaoT. OkadaY. YasakaM. OoboshiH. IrieK. OmaeT. NakaneH. SugimoriH. ArakawaS. FukudaK. KitayamaJ. FujimotoS. ArihiroS. KurodaJ. WakisakaY. FukushimaY. KumaiY. MakiharaN. TakadaJ. Left atrial size and long‐term risk of recurrent stroke after acute ischemic stroke in patients with nonvalvular atrial fibrillation.J. Am. Heart Assoc.201768e00640210.1161/JAHA.117.00640228862939
    [Google Scholar]
  29. PradellaM. BarabooJ.J. PrabhakaranS. ZhaoL. HijazT. McCombE.N. NaidichM.J. HeckbertS.R. NasrallahI.M. BryanR.N. PassmanR.S. MarklM. GreenlandP. MRI investigation of the association of left atrial and left atrial appendage hemodynamics with silent brain infarction.J. Magn. Reson. Imaging2024jmri.29349Online ahead of print10.1002/jmri.2934938490945
    [Google Scholar]
  30. ChenY.C. VoskoboinikA. GercheA.L. MarwickT.H. McMullenJ.R. Prevention of pathological atrial remodeling and atrial fibrillation.J. Am. Coll. Cardiol.202177222846286410.1016/j.jacc.2021.04.01234082914
    [Google Scholar]
/content/journals/cnr/10.2174/0115672026354260241218115435
Loading
/content/journals/cnr/10.2174/0115672026354260241218115435
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test